Industry Trends
An Analysis of Worldwide Prescription and OTC Sales by Technology
(2002 - 2012)
By Mark P. Mathieu
EvaluatePharma® calculates that worldwide pharmaceutical sales from biotechnology products increased 20%, to $94bn, in 2007.
Read more
|
Latest eNewsletters
eCliniqua
More Quintiles Work Going to 'Prime Sites'
January 19, 2010
Pharma Services
News
Gentris Profile; PSN 2008 Highlights Report
January 13,2010
|
 |
Sales Contacts
For advertising information contact: Alan El Faye
VP, Advertising Sales - Western US, Canada, Europe, Pacific Rim
213-300-3886
Kay O. Christopher
Regional Sales Manager, Advertising Sales - Eastern US, Midwest and India
860-693-2991
|
| |
Link to Us!
You are welcome to link to articles on our website. Contact Allison Proffitt for details.
e-Prints & Reprints
To post a full article from Weekly Update or Bio-IT World on your website (not just a link), or for paper reprints, please contact:
Ashley Zander
The YGS Group
717-505-9701 ext.125
|
|
|
| |
| IN THIS ISSUE |
 |
GSK Invites Academic Collaboration in Singapore, Announces Open Innovation Agenda |
| |
deCODE Appoints New CEO, Emerges from Bankruptcy |
| |
Quantum Leaps Into Life Sciences Data Management With StorNext 4.0 |
| |
Navigenics Names Vance Vanier New CEO |
| |
Illumina's HiSeq 2000: Secrets and Buys |
|
 |
| |
Request For Proposal: S09-204 caTissue 1.2 Adopters
SAIC-Frederick, Inc., in support of the Cancer Biomedical Informatics Grid (caBIG) Program, is requesting proposals for caTissue 1.2 Adopters. The Request for Proposal may be downloaded from https://www.fbo.gov/RFP_S09-204_caTissue_1.2_Adopters. All proposals must be received by 4:00 p.m. (EST) on February 19, 2010. Please see Section L: Instructions, Conditions, and Notices to Offerors for Proposal Preparation Instructions.
The main objective of this project is to promote further adoption of caTissue Suite, encouraging data sharing on tissue specimen collections, facilitating tissue sampling distributions and enhancing collaboration among researchers and clinicians regarding tissue samples and related information. The primary focus of this release will improve interoperability with other caBIG products; integrate with assay systems like caArray, caBIG Clinical Trials Suite (CCTS), NCI Enterprise Services (NES), and the Biospecimen Research Database; improve interoperability by implementing the Common Biorepository Model (CMB); improve grid compatibility, quality, performance and scalability by re-factoring and re-architecting the existing system.
|
| |
| |
| THIS WEEK IN BIO-IT |
| |
GSK Invites Academic Collaboration in Singapore, Announces Open Innovation Agenda
By Allison Proffitt
SINGAPORE-GlaxoSmithKline launched the GlaxoSmithKline-Singapore Academic Centre of Excellence (ACE) on Monday, with a two-day ACE symposium. The symposium follows closely on last Wednesday's announcement by Andrew Witty, chief executive of GlaxoSmithKline, of an open innovation strategy, much of which so far is targeted at developing drugs and a vaccine for malaria. Read more.
|
|
| |
deCODE Appoints New CEO, Emerges from Bankruptcy
By Bio-IT World
Iceland's deCODE genetics ehf has emerged from bankruptcy as a private company focused on human genetics research, genetic diagnostics, and personal genomics, with former Genzyme executive Earl "Duke" Collier stepping in as CEO. Read more.
|
|
| |
Quantum Leaps Into Life Sciences Data Management With StorNext 4.0
By Kevin Davies
With one eye firmly on the soaring data demands in life sciences and next-generation sequencing, San Jose-based Quantum Corp. has released version 4.0 of its scalable StorNext data management software for facile backup, archiving and deduplication. Read more.
|
|
| |
Navigenics Names Vance Vanier New CEO
By Bio-IT World Staff
Navigenics has appointed chief medical officer Vance Vanier as its new president and CEO, succeeding Jonathan 'Jack' Lord and becoming the consumer genomics firm's third chief executive since its launch in April 2008. Read more.
|
| |
| |
Genetics on the Big Screen
By Bio-IT World Staff
"Extraordinary Measures," starring Harrison Ford and Brendan Fraser, chronicles Myozyme, the first and only FDA-approved product to treat Pompe disease. Myozyme was developed by Genzyme Corporation and it was developed based on research conducted by Genzyme in collaboration with researchers at Duke University and the Erasmus Medical Center in The Netherlands. Read more.
|
| |
| |
New Factor to Create Stem Cells
By Allison Proffitt
SINGAPORE--Scientists from the Genome Institute of Singapore yesterday published the fourth transcription factor known to revert differentiatied cells into stem cells. The study was published in Cell Stem Cell. Read more.
|
| |
| |
Illumina's HiSeq 2000: Secrets and Buys
By Kevin Davies
If Illumina's new HiSeq 2000 sequencer proves even half as effective as the invisibility cloak that the San Diego firm deployed before dramatically revealing its existence last week, then it has a good shot to "redefine the trajectory of sequencing," as Illumina CEO Jay Flatley told analysts last week. Read more.
|
| |
| |
|
|
| |
 |
| |
| |
| ELSEWHERE IN THE PRESS |
| |
Biotech's Year in Wonderland
A year ago things were looking bleak for biotech, but now biotech is cautiously optimistic. Although 2009 did see dozens of companies failing or being bought for a song, many survived cost cutting and trimming. 2009 ended with three big IPOs and some lucrative parternships between big pharma and biotech. CNN Money
|
|
|
BIO-IT WORLD January-February 2010
ISSUE HIGHLIGHTS |
| |
|
Drug Discovery in Dundee:
A Q&A with Andrew Hopkins
By Kevin Davies
While working at Pfizer 9 years ago, Andrew Hopkins and his colleague Colin Groom coined the phrase "the druggable genome"-a systematic analysis of the number of druggable targets in the human genome. In 2007, Hopkins made the bold decision to quit industry for academia. Now, with patents filed, compounds being synthesized, biophysics and informatics operations up and running, Hopkins granted Bio•IT World this exclusive interview. Read more.
|
|
| |
An Emerald in the Rough
By Kevin Davies
Late last year, scientists at Emerald BioStructures experienced the bittersweet ride that so often characterizes the drug discovery business. In August 2009, a team led by CEO Lance Stewart published a major paper outlining the application of a Fragments of Life (FOL) drug discovery approach to help identify an exciting small-molecule drug candidate, DG051, in the Journal of Medicinal Chemistry. But publication came just a few months before Emerald severed ties with deCODE genetics after the Icelandic firm filed for bankruptcy in November. Read more.
|
|
|
 |
|
| |
WEBINAR
Next-Generation Clinical Trial and Data Management Applications
Sponsored by Adobe
This webinar introduces i3Cube - a web-based, fully integrated, clinical trial and data management system built on Adobe's LiveCycle® Enterprise Suite. I3 cube provides end-to-end automation that delivers unprecedented visibility into information that sponsors need to accelerate the study process and complete trials efficiently. Viewers will learn more about:
- Creating faster and more efficient trial processes
- Reducing investigator burden
- Real-time sponsor transparency into study information
- Enterprise solutions based on Adobe LiveCycle® ES utilizing cross-platform clients of Reader, Flash and AIR
Download now.
To have your podcast featured here, contact Lynn Cloonan for more information.
|
|
| |
SPONSORED LINKS
To have your product or service featured here, contact Lynn Cloonan for more information.
|
|
| |
Insight Pharma Reports
Multiplex Assays: Evolving Technologies, Applications, & Future Directions
Author: Ken Rubenstein, Ph.D.
Multiplex Assays has generated a great deal of excitement in the past 15 years. This report examines the role of multiplex and multi-analyte biomarker assays in translational medicine. Read more.
|
|
| |
FEATURED EVENTS
- Adopting R&D Informatics Systems
- Molecular Med Tri-Conference Short Courses
- Tufts Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation | Feb 8-12, 2010 | Boston
- Electronic Data in Clinical Trials, March 8-9, 2010, Philadelphia
- eCTD 2010 - One Day Forum, March 10, 2010, Philadelphia
- Summit for Clinical Ops Executives (SCOPE) - March 8-11, 2010 | Philadelphia
- Drug Development Latin America, March 10-11, 2010, Philadelphia
- Bio-IT World Conference & Expo • April 20-22, 2010, World Trade Center •Boston, MA
- Bio-IT World Web Symposia Series
- Barnett Educational Services
- Cambridge Healthtech Events
To have your event featured here, contact Lynn Cloonan for more information.
|
|
|
|
| |
BEST PRACTICES 2010
Deadline Extended |
The deadline for the 2010 Bio-IT World Best Practices Awards Program has been extended to February 19, 2010.
Share your organization's best practices with your peers. The Best Practices program recognizes individuals and teams for their novel and innovative uses of technology, business strategies, and solutions that improve some facet of the R&D / drug development / clinical trial process. Direct entries are encouraged as well as nominations from users and vendors.
"We're excited about this award and very honored to be a recipient of Best Practices from Bio-IT World." -Vanderbilt University; ActiveHealth Management
Submission details and entry form are available here. Deadline extended to February 19, 2010.
View the 2009 Best Practices Awards compendium today.
2010 Best Practices Categories
- Basic Research & Biological Research
- Drug Discovery & Development
- Clinical Trials & Research
- Translational Medicine
- Personalized Medicine
- IT & Informatics
- Knowledge Management
- Health-IT
- Manufacturing & Bioprocessing
If you have questions, write to aproffitt@healthtech.com
|
| |
| FEATURED CONTENT |
StorNext 4.0: Technical Product Brief 
Proven in the world's most data intensive industries, Quantum StorNext is a scalable, high-performance file system which allows data sharing across Linux, Mac, Unix, and Windows operating systems and manages data in enterprise storage environments. Download Whitepaper (Sponsored by: Quantum )
The Key to Life Sciences Data  Management: Transparent Migration Life sciences organizations face new data management challenges as the volume of research data grows and more data is kept online for longer times. Download Whitepaper (Sponsored by: BlueArc)
Protect Your Scientific Intellectual  Property: Proof of Lab Informatics Data Authenticity is Your Best Legal Defense
As a bio-technology or life sciences organization, your formulas, treatments and research and discoveries are the "lifeblood" of your business. But if you aren't protecting the integrity of your scientific data in your lab informatics systems, you risk losing IP ownership, revenue and consequently your business if you can't prove time-of-creation and data authenticity. Learn how you can implement simple, cost-effective and automated controls to protect your scientific intellectual property. Download Whitepaper (Sponsored by: Surety, LLC)
To have your white paper featured here, contact Lynn Cloonan for more information.
|
| |
| EXCLUSIVE WEBCAST |
Life Science Webcasts from Bio-IT World and Cambridge Healthtech Media Group
Moore's Law and the Future of Genome Sequencing
Guest: Jonathan Rothberg, Ph.D., Founder/CEO Ion Torrent Systems; Founder Curagen, 454 Life Sciences, Rain Dance
Editorial inteview conducted by Kevin Davies, Ph.D., Editor-in-Chief of Bio-IT World with Jonathan Rothberg reflecting on the past decade of his accomplishments and a glimpse at his new project, Ion Torrent Systems. Interview conducted at CHI's Exploring Next Generation Sequencing conference in September 2009. Download Now
Oxford Nanopore's Third-Generation Sequencing Technology
Guest: John Milton, Ph.D., Vice President Research, Oxford Nanopore Technologies UK
Editorial interview conducted by Kevin Davies, Ph.D., Editor-in-Chief of Bio-IT World with John Milton that offers insights into Oxford Nanopore's potentially revolutionary new sequencing technology, which marries exonuclease cleavage of DNA and protein nanopores. Interview conducted at CHI's Exploring Next Generation Sequencing conference in September 2009. Download Now
|
| |
| Contact the Editor |
We invite your comments and feedback for this edition of Weekly Update.
Managing Editor
|
|
Follow
